The qRT‐PCR data revealed an increased expression of HSP90AA1 in the SLE‐MS group compared with HCs, and a decreased expression of HSP90AA1 after hUC‐MSCs treatment compared with the SLE‐MS group (Figure 7B). This evidence concerns the gene HSP90AA1 and myeloid sarcoma.